Aurora Cannabis Inc (ACB) reports a 29% increase in net revenue, driven by a 93% surge in international medical cannabis ...

Greetings, and welcome to the Aurora Cannabis Inc. second quarter 2025 results conference call. [Operator instructions] This ...

Aurora Cannabis Inc. (NASDAQ: ACB) Q2 2025 Earnings Call Transcript November 6, 2024 ...

Q2 2025 Earnings Conference Call November 6, 2024 8:00 AM ETCompany ParticipantsKevin Niland - Director, Strategic ...

Aurora Cannabis reported quarterly revenue of CA$81.1 million, up from CA$63.1 million in the same period last year. Strong results are attributed to Aurora’s ability to capitalize on opportunities in ...

Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid ...

CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical ...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced its financial results for the fiscal 2025 second quarter. Total revenue rose year-over-year and the company has a positive outlook for the ...

ACB Record Adjusted EBITDA1 of $10.1 Million, a YoY increase of 210% Quarterly Net Revenue1 up 29% YoY to $81.1 Million, with 41% growth in Global ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

As of November 08, 2024, Aurora Cannabis Inc. had a $277.8 million market capitalization, putting it in the 34th percentile of companies in the Pharmaceuticals industry. Aurora Cannabis Inc. does not ...